Meditor Group Ltd

All Holdings — 2024 Q3

AI Portfolio Summary
In 2024 Q3, Meditor Group Ltd maintained a portfolio of 4 distinct positions. The fund also reduced its exposure to EXELIXIS INC by 22.3%.
PCA Score Concentration Risk
Risk ENB
Total Positions
4
Quarter
2024 Q3
Top Holding
EXEL (73.4%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-4 of 4
Stock History Sector / Type Port % Prev % Rank / Prev Conviction Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
EXEL
EXELIXIS INC
Healthcare 73.43% 72.86% #1
Prev: #1
10.0 -390,550 -22.3%
P
S
1,362,450 $35,355,578 2011 Q4 13F Filing 2024-09-30 2024-11-14 (Est.)
ESPR
ESPERION THERAP...
Healthcare 12.99% 15.57% #2
Prev: #2
5.2 no change no change
P
S
3,791,300 $6,255,645 2017 Q2 13F Filing 2024-09-30 2024-11-14 (Est.)
INDA
ISHARES MSCI IN...
ETF 7.22% 6.15% #3
Prev: #3
2.9 no change no change
P
S
59,400 $3,474,900 2016 Q2 13F Filing 2024-09-30 2024-11-14 (Est.)
EPI
WISDOMTREE INDI...
ETF 6.36% 5.42% #4
Prev: #4
2.5 no change no change
P
S
60,700 $3,062,922 2016 Q2 13F Filing 2024-09-30 2024-11-14 (Est.)
Showing 1-4 of 4 holdings

Unlock Full Meditor Group Ltd Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics